Avenue Therapeutics, Inc.
Price Action
Technical Summary
WEAKENINGAvenue Therapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings growth of 89% provides fundamental context to the price action. However, price is extended 63% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.50 | +10.33% | ABOVE |
| 50 SMA | $0.34 | +62.64% | ABOVE |
| 100 SMA | $0.44 | +25.62% | ABOVE |
| 150 SMA | $0.55 | +0.53% | ABOVE |
| 200 SMA | $0.55 | -0.11% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ATXI in an uptrend right now?
ATXI has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ATXI overbought or oversold?
ATXI's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is ATXI outperforming the market?
ATXI has a Relative Strength (RS) Rating of 94 out of 99. Yes, ATXI is a market leader, outperforming 94% of all stocks over the past 12 months.
Where is ATXI in its 52-week range?
ATXI is trading at $0.55, which is 57% of its 52-week high ($0.97) and 49% above its 52-week low ($0.15).
How volatile is ATXI?
ATXI has a Beta of -0.11 and 52-week volatility of 266%. It's less volatile than the S&P 500 - generally more stable.